Europan Union Register of nutrition and health claims made on food - Rejected health claims
This page has moved ! If you are not redirected please click here
Rejected health claims
- Article 14(1)(a) health claims referring to the reduction of a risk factor in the development of a disease
- Article 14(1)(b) health claims referring to children's development and health
- Article 13(5) health claims based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Article 14(1)(a) health claims referring to the reduction of a risk factor in the development of a disease
|
Nutrient, substance, food or food category
|
Claim
|
Reasons for rejection
|
EFSA opinion reference
|
Commission Regulation
|
| ACTIMEL® Lactobacillus casei DN-114 001 plus yoghurt symbiosis | Fermented milk containing the probiotic Lactobacillus casei DN-114 001 and yoghurt symbiosis decreases presence of Clostridium difficile toxins in the gut (of susceptible ageing people). Presence of Clostridium difficile toxins is associated with the incidence of acute diarrhoea. | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Q-2009-00776 | Commission Regulation (EU) No 1160/2011 of 14 November 2011  |
| OPC Plus | OPC Plus has been shown to increase the microcirculation and may therefore reduce the risk of chronic venous insufficiency | Non-compliance with the Regulation as, on the basis of the dossier, the evidence provided did not establish that improving the “alterations in the venous microcirculation” is a beneficial physiological effect by reducing the risk of chronic venous insufficiency. A cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established | Q-2009-00751 | Commission Regulation (EU) No 665/2011 of 11 July |
| Soy protein | Soy protein has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-00672 | Commission Regulation (EU) No 1160/2011 of 14 November 2011 |
| OPC Premium™, containing 40 mg oligomeric procyanidins (OPC) and 400 mg berry-blend per capsule. | OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised with respect to the berry blend, whereas the active constituent extracted from grape (Vitis vinifera) seeds is sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2009-00454 | COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010 |
| Uroval®, food supplement containing cranberry extract and D-mannose | Cranberry extract and D-mannose, the main active ingredients of the food supplement Uroval®, eliminate the adhesion of harmful bacteria to the bladder wall. The adhesion of harmful bacteria to the bladder wall is the main risk factor in the development of urinary tract infections | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-00600 | COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010 |
| Calcium containing fruit juices | Reduced risk for dental erosion | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-00501 | Commission Regulation (EU) No 1170/2011 of 16 November 2011 |
| BimunoTM (BGOS) Prebiotic | Regular consumption of BimunoTM (BGOS) Prebiotic helps to protect against the bad bacteria than can cause the travellers’ diarrhoea | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-00232 | Commission Regulation (EC) No 384/2010 of 5/05/2010 |
| Water | Regular consumption of significant amounts of water can reduce the risk of development of dehydration and of concomitant decrease of performance | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, the proposed risk factors are measures of the disease and a risk factor in the development of a disease is not shown to be reduced. | Q-2008-05014 | Commission Regulation (EU) No 1170/2011 of 16 November 2011 |
| Lycopene-whey complex | Lycopene-whey complex prevents oxidative damage of plasma lipoproteins, which reduces the build up of arterial plaques and reduces the risk of heart disease, stroke and other clinical complications of atherosclerosis | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2008-703 | Commission Regulation (EC) No 384/2010 of 5/05/2010 |
| NeOpuntia®, containing dehydrated leaves of the prickly pear cactus (Opuntia ficus-indica) | NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2008-214 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Lactobacillus helveticus fermented Evolus® low-fat milk products | Evolus® reduces arterial stiffness. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-218 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Melgaço® naturally sparkling mineral water | The regular consumption of Melgaço mineral water reduces body hyperglycaemic levels | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-219 | Commission Regulation (EC) No 1167/2009 of 30/11/2009 |
| Ocean Spray Cranberry Products®, juice drinks and sweetened dried berries Craisins® | Regular consumption of 2 servings per day of an Ocean Spray product each containing typically 80 mg cranberry proanthocyanidins helps reduce the risk of urinary tract infection in women by inhibiting the adhesion of certain bacteria in the urinary tract | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-117 | Commission Regulation (EC) No 1167/2009 of 30/11/2009 |
Article 14(1)(b) health claims referring to children's development and health
|
Nutrient, substance, food or food category
|
Claim
|
Reasons for rejection
|
EFSA opinion reference
|
Commission Regulation
|
| Immunofortis® | Immunofortis® to naturally strengthen your baby’s immune system | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Q-2008-106 | Commission Regulation (EU) No 1162/2010 of 9 December 2010 refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health |
| Docosahexaenoic acid (DHA) and arachidonic acid (ARA) | Docosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children. | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Q-2008-212 | Commission Regulation (EU) No 440/2011 of 6 May 2011 |
| Lipil® | Lipil® contributes to optimal brain development of infants and young children. | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Q-2008-690 | Commission Regulation (EU) No 440/2011 of 6 May 2011 |
| Enfamil® Premium | Enfamil® Premium contributes to optimal brain development of infants and young children. | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Commission Regulation (EU) No 440/2011 of 6 May 2011 |
|
| Eye qTM | Eye qTM (a unique combination of High-EPA/DHA/GLA omega-3, 6 PUFA) provides the essential nutrients that helps improve working memory in children | Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect | Q-2009-00485 | Commission Regulation (EU) No 1162/2010 of 9 December 2010 refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health |
| Mixture of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) | Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2009-00224 | COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010 |
| regulat®.pro.kid IMMUN, food supplement with fermented vegetables and fruits, probiotics lecithin and rhodiola rosea extract | regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-082 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| regulat®.pro.kid.BRAIN, food supplement with probiotics and fermented vegetables and fruits | regulat®.pro.kid.BRAIN contributes to mental and cognitive development of children | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-083 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Calming | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-091 & Q-2008-096 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Provide serenity and room for a beneficial development of the child | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established - the effect has not been sufficiently defined |
Q-2008-092 & Q-2008-097 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Helps to promote the thinking capacity | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-093 & Q-2008-101 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Help to promote concentration | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-094 & Q-2008-099 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Help to support vision | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-095 & Q-2008-100 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Help to support mental development | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-098 & Q-2008-104 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® | Help to support the learning ability | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-102 & EFSA-Q-2008-103 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Eye q baby®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) | Eye q baby® provides the nourishments that support healthy central nervous system development | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-119 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Eye q®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) | Eye q® provides the nourishments that help to maintain healthy brain functions | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-329 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Eye q®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) | Eye q® provides the nourishment that help children to maintain concentration levels | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-330 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Mumomega®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) | Mumomega® provides the nourishments that support healthy central nervous system development. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-328 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) | DHA & ARA support neural development of the brain and eyes. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-120 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) | Efalex® may help maintain coordination. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-121 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) | Efalex® may help maintain concentration. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-317 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) | Efalex® may help maintain and support brain development and function. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-318 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) | Efalex® may help maintain learning ability. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-319 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) | Efalex® may help maintain and support eye development and function. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-320 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Dairy products (milk, cheese and yoghurt) | Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-110 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Dairy products (milk and cheese) | Dairy foods (milk and cheese) promote dental health in children. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-112 | Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum | LACTORAL helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens). | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-269 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum | LACTORAL is recommended in order to improve the general immunity by maintaining the microbiological balance. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-477 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum | LACTORAL helps to protect the alimentary system against enteric pathogens because of strong antagonistic properties and helps to build the natural intestinal barrier. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-478 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum | LACTORAL helps to maintain natural intestinal microflora during travel, changing the climatic zone or a diet, especially in poor hygiene conditions. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-479 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum | LACTORAL contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed-infant | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - the effect has not been sufficiently defined - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2008-480 | Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Kinder Chocolate®, chocolate bar | Kinder Chocolate, the chocolate that helps to grow | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-283 | Commission Regulation (EC) No 1167/2009 of 30/11/2009 |
| Follow-on formulae with a fixed combination of short-chain galacto-oligosaccharides, acidified milk, nucleotides and beta-palmitate | Aids minor intestinal ailments (as colic, constipation, digestive symptoms) | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-270 | Commission Regulation (EC) No 1167/2009 of 30/11/2009 |
Article 13(5) health claims based on newly developed scientific evidence and/or including a request for the protection of proprietary data
|
Nutrient, substance, food or food category
|
Claim
|
Reasons for rejection
|
EFSA opinion reference
|
Commission Regulation
|
| Lactobacillus plantarum TENSIATM | Regular consumption (at least three weeks) of 50 g/day Südamejuust ("heart cheese") of HarmonyTM brand comprising probiotic Lactobacillus plantarum TENSIATM helps to maintain the cardio-vascular system/heart health through reduction of blood pressure /symbol of heart |
Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2010-00950 | Commission Regulation (EU) No 1171/2011 of 16 November 2011 |
| Live Lactobacillus casei strain Shirota | Daily consumption of live Lactobacillus casei strain Shirota as present in a fermented milk product helps maintain the upper respiratory tract defences by helping to support immune functions |
Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2010-00137 | Commission Regulation (EU) No 1171/2011 of 16 November 2011 |
| Ethanol-water extract of Caralluma fimbriata (Slimaluma®) | Slimaluma® helps to control hunger/appetite |
Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Q-2010-00031 | Commission Regulation (EU) No 432/2011 of 4 May 2011 |
| Ethanol-water extract of Caralluma fimbriata (Slimaluma®) | Slimaluma® helps to reduce caloric intake |
Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Commission Regulation (EU) No 432/2011 of 4 May 2011 | |
| Ethanol-water extract of Caralluma fimbriata (Slimaluma®) | Slimaluma® helps to reduce body weight |
Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Commission Regulation (EU) No 432/2011 of 4 May 2011 |
|
| Ethanol-water extract of Caralluma fimbriata (Slimaluma®) | Slimaluma® helps to reduce body fat | Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Commission Regulation (EU) No 432/2011 of 4 May 2011 |
|
| Ethanol-water extract of Caralluma fimbriata (Slimaluma®) | Slimaluma® helps to reduce waist circumference | Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established | Q-2010-00027 | Commission Regulation (EU) No 432/2011 of 4 May 2011 |
| Silymarin BIO-C® | Suggested for improving the physiological production of breast milk during breast feeding | Non-compliance with the Regulation as, on the basis of the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established | Q-2009-00957 | Commission Regulation (EU) No 666/2011 of 11 July 2011 |
| Synbio | Synbio persists in the intestinal tract and favours the natural regularity contributing to maintain and improve human intestinal well-being | Non-compliance with the Regulation as, on the basis of the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established | Q-2009-00889 | Commission Regulation (EU) No 666/2011 of 11 July 2011 |
| Catalgine® bouffées de chaleur | Contributes to the reduction in the number of hot flushes | Non-compliance with the Regulation as, on the basis of the evidence submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-00852 | Commission Regulation (EU) No 1161/2010 of 9 December 2010 refusing to authorise a health claim made on foods, other than those referring to the reduction of disease risk and to children’s development and health |
| Combination of blackcurrant seed oil (Ribes nigrum), fish oil, lycopene from tomato (Lycopersicon esculentum) extract, vitamin C and vitamin E | Helps to improve dry skin condition | Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established | Commission Regulation (EU) No 432/2011 of 4 May 2011 | |
| Immune Balance Drink, containing vitamin C, green tea extract, grape skin extract, grape seed extract, and shiitake mushroom extract | The Immune Balance Drink activates body's defence | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2009-517 | COMMISSION REGULATION (EU) No 958/2010 of 22 October 2010 |
| Lactobacillus plantarum 299v (DSM 9843) | Lactobacillus plantarum 299v (DSM 9843) improves iron absorption | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-785 | COMMISSION REGULATION (EU) No 375/2010 Of 3 May 2010 |
| Yestimun® | Daily administration of Yestimun® strengthens the body’s defence during the cold season |
Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established |
Commission Regulation (EU) No 432/2011 of 4 May 2011 | |
| Milk product, rich in fibre and protein | This product reduces the sense of hunger | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-396 | COMMISSION REGULATION (EU) No 383/2010 Of 3 May 2010 |
| Natural Push-Up® Tablets and Natural Push-Up® Capsules | NPU Tablets imitate female breasts enhancement process by 8-PN (8-Prenylnaringenin) | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-784 | COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010 |
| Bimuno BT (BGOS) Prebiotic | Helps maintain a healthy gastro-intestinal (GI) function | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2009-00231 | COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010 |
| Bimuno BT (BGOS) Prebiotic | Supports your natural defences | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2009-00230 | COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010 |
| Gum Periobalance TM tablets and chewing gum | Gum Periobalance TM , combined with a correct oral hygiene, helps re-balancing the oral microflora and improving oral health | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2009-00373 | COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010 |
| Elancyl Global Silhouette®, a combined product containing either conjugated linoleic acid or a mix extract of plants and cocoa extract as active ingredients | Clinically tested as of 14 days. Your silhouette is apparently and globally redrawn, resculpted and refined at 28 days. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - the food for which the claim is made has not been sufficiently characterised - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-285 | Commission Regulation (EC) No 984/2009 of 21/10/2009 |
| LGG® MAX multispecies probiotic consisting of four bacterial trains | LGG® MAX helps to reduce gastro-intestinal discomfort. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-444 | Commission Regulation (EC) No 984/2009 of 21/10/2009 |
| Dairy product (milk beverage) enriched with milk peptide and magnesium | Helps to moderate signs of anxiety in mildly stress-sensitive adults due to its milk peptide and magnesium content. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-476 | Commission Regulation (EC) No 1025/2009 of 29/10/2009 |
| Black tea from Camellia sinensis | Black tea helps you to focus attention. | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. |
Q-2008-434 | Commission Regulation (EC) No 1025/2009 of 29/10/2009 |
| Algatrium®, containing DHA as raw material for foods/food supplements | Algatrium® promotes your antioxidant response: a singular nutritional substance that has scientifically demonstrated in humans a stimulation of the own cells antioxidant defences | Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. | Q-2008-705 | Commission Regulation (EC) No 1168/2009 of 30/11/2009 |